Hyperuricemia as an independent risk factor for metabolic dysfunction-associated fatty liver disease in nonobese patients without type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Hyperuricemia as an independent risk factor for metabolic dysfunction-associated fatty liver disease in nonobese patients without type 2 diabetes mellitus

Published:2023-07-01 Issue:1 Volume:325 Page:E62-E71
ISSN:0193-1849
Container-title:American Journal of Physiology-Endocrinology and Metabolism
language:en
Short-container-title:American Journal of Physiology-Endocrinology and Metabolism

Author:

Liu Jing¹^ORCID,Wang Che²^ORCID,Wang Yu-Tong²^ORCID,Liu Ji-Xiang³^ORCID,Zhou Tian-Hui³^ORCID,Yao Shu-Kun⁴^ORCID,Chen Gang⁵^ORCID

Affiliation:

1. China-Japan Friendship Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

2. School of Qi Huang, Beijing University of Chinese Medicine, Beijing, China

3. Beijing University of Chinese Medicine, Beijing, China

4. Department of Gastroenterology, China-Japan Friendship Hospital, Beijing, China

5. Examination Center, China-Japan Friendship Hospital, Beijing, China

Abstract

HUA is an independent risk factor for MAFLD in nonobese patients without T2DM. The association of HUA with MAFLD in nonobese patients without T2DM increased gradually with aging, especially in those over 40 yr old. In nonobese patients without T2DM, univariate analysis showed that females with HUA had a higher risk of MAFLD than males. However, the difference was narrowed after adjustment for confounders.

Publisher

American Physiological Society

Subject

Physiology (medical),Physiology,Endocrinology, Diabetes and Metabolism

Link

https://journals.physiology.org/doi/pdf/10.1152/ajpendo.00001.2023

Reference32 articles.

1. Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals

2. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

3. Serum uric acid levels are associated with homeostasis model assessment in obese nondiabetic patients: HOMA and uric acid

4. High serum uric acid and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis

5. Metabolic syndrome, diabetes, and hyperuricemia